logo
World-first clinical trial launched in Southampton for a fridge-free vaccine

World-first clinical trial launched in Southampton for a fridge-free vaccine

ITV News29-04-2025
A world-first clinical trial has been launched in the UK for a fridge-free vaccine, which could greatly increase access to jabs.
The Stablepharma tetanus-diphtheria vaccine (SPVX02) is completely stable at room temperature and the firm behind it says up to 60 other vaccines may benefit from the advanced technology.
The first-in-human trial of the vaccine is taking place at the National Institute for Health and Care Research (NIHR) Southampton clinical research facility at University Hospital Southampton.
One of the biggest barriers to people getting vaccines in some parts of the world is the 'cold chain' required to keep vaccines cold from manufacture to the point they are injected.
The World Health Organisation (WHO) estimates that up to half of vaccines are wasted globally every year – largely because of a lack of temperature control and the logistics needed to support an unbroken cold-chain.
UK-based biotech company Stablepharma has shown it can convert existing approved vaccines to fridge-free versions that can be stored for long periods of time at room temperature.
Health and Social Care Secretary, Wes Streeting, said: 'For years, vaccines have been held back by the need to be stored in a fridge – causing endless amounts of wastage and making it difficult to deliver them to remote communities.
'But thanks to this Government's vision and our investment through the National Institute for Health and Care Research, all that could be about to change.
'We are leading the charge by pushing through the world's first trial for fridge-free vaccines.
'This could be a real game changer and lifesaver globally – as it unlocks new ways for poorer nations to deliver vaccines to their patients, where they're often needed the most.
'Groundbreaking science is amongst the things that Britain does best, and this innovation reaffirms our position as a world leader in vaccine development and research, boosting growth and economic security – the cornerstone of our Plan for Change.'
The clinical trial is being led by Professor Saul Faust from the University of Southampton and Stablepharma chief development officer, Dr Karen O'Hanlon.
Prof Faust said: 'It is fantastic to see cutting-edge UK science reach the milestone of a first clinical trial and to be able to give the opportunity for people living on the south coast to take part.
'This research will be an important step toward exploring whether this innovation could eradicate vaccine wastage and move away from the need for the cold-chain.'
The trial is expected to complete this summer, with results published by the end of the year.
Stablepharma hopes the new vaccine will be in use globally by 2027.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Unique blood test could catch cancer early
Unique blood test could catch cancer early

The Independent

time30 minutes ago

  • The Independent

Unique blood test could catch cancer early

A new clinical trial, Enlighten, is assessing a blood test designed to detect 10 different types of cancer in their very early stages. Developed by Proteotype Diagnostics and led by the Southampton Clinical Trials Unit, the test identifies specific proteins in the blood that indicate the immune system's response to initial cancer signs. Unlike other tests focusing on abnormal DNA, Enlighten targets protein levels, which experts believe are more effective for detecting cancer at its earliest stages. The Modernised trial aims to recruit 1,000 patients across various solid tumour types, with 450 already participating, and is running at multiple hospital sites in the UK. Researchers emphasise that early cancer detection, facilitated by such tests, is crucial for improving treatment options and increasing successful outcomes for patients.

Bird flu confirmed at commercial poultry farm near Tiverton
Bird flu confirmed at commercial poultry farm near Tiverton

BBC News

time31 minutes ago

  • BBC News

Bird flu confirmed at commercial poultry farm near Tiverton

Bird flu has been confirmed at a farm in Devon, the Department for Environment, Food and Rural Affairs (Defra) has said the case had occurred at a commercial poultry business near Tiverton on Wednesday and that all birds at the site would be humanely culled. A 3km (1.9 mile) protection zone and 10km (6.2 mile) surveillance zone has been declared around the keeping poultry or other captive birds within the two zones must keep them housed and a record of all people who enter or leave the property, Defra said. It comes after a case of bird flu was confirmed in poultry near Minehead and Dulverton in Somerset on Scotland and Wales have been designated an avian influenza prevention zone (AIPZ) with mandatory biosecurity measures in place until further AIPZ measures apply to all bird keepers whether they have pet or commercial biosecurity is essential to protecting flocks from bird flu, Defra added.

Sir David MacMillan: 'I'd bet my house' on treatment for Alzheimer's
Sir David MacMillan: 'I'd bet my house' on treatment for Alzheimer's

BBC News

time31 minutes ago

  • BBC News

Sir David MacMillan: 'I'd bet my house' on treatment for Alzheimer's

A Nobel Prize-winning Scottish chemist has told the BBC he thinks drugs to treat Alzheimer's disease will be available within five University's Prof David MacMillan, who is originally from North Lanarkshire, said "phenomenal things" are happening within medical research into neurological diseases."I would bet my house that within five years that we have marketed drugs for Alzheimer's," Prof MacMillan told the BBC's Scotcast podcast."My father died of vascular dementia and my aunt had dementia. I think that's such a horrible way to go." The Scottish scientist was awarded the 2021 Nobel Prize in Chemistry alongside Prof Benjamin List after developing a new way of building molecules. Their work has led to developments in drugs for Alzheimer's, cancer and heart MacMillan, 57, said the award had made a massive impact on his life"On a Tuesday morning, I was a chemist that nobody, including half my pals, had been interested in talking to," he said."Then on the Wednesday, I was talking to like the New York Times and the Wall Street Journal."It was crazy - and I thought it would slow down but it just keeps on going."Prof MacMillan was awarded a half share of 10 million Norwegian krona (£842,611).He used it to set up The May and Billy MacMillan Foundation, named after his parents, where he funds Scottish students, providing educational opportunities to underprivileged young said education and learning was always good and gaining more experience was incredibly important. Passport to the world It is something he knows about from his own grew up in New Stevenston, near Bellshill, and gained his undergraduate degree in chemistry at the University of Glasgow before moving to the US for postgraduate studies."I realised that education is your passport to the world," he studying in California in the early 1990s, he moved to Harvard and the University of California at Berkeley before becoming a professor at Princeton in said working in the US had been great because its "research is the infrastructure that drives the health of the world".The possibilities of the people he was able to collaborate with had been "mind-boggling", he said. However, recent developments in US universities are causing concern, he Donald Trump and his Vice-President JD Vance have long railed against higher education institutions and they have been putting pressure on them over the first time in 25 years, Prof Macmillan's research group at Princeton has received no funding for the first seven months of the year from the US government. He said: "Americans still care about the Nobel Prize."If that could happen to somebody like me, it could happen to anybody."The scientist said that academics were now the resistance as they try to deal with the politics of the current US administration "without selling their soul".Prof MacMillan said the cuts were "quite sinister" because it seemed like a way to control universities and the narrative by deciding who they can hire. Higher education has become a hub for progressive thinking, which in his opinion, he said the Republicans don't like. "What they care the most about is retaining power," he said. Despite the pressure in the US, Prof MacMillan is not planning a return to Scotland just yet but he does regularly come back to see family - and some newfound friends. He told the podcast he had become good friends with a Scottish legend who phoned to congratulate him after he won the Nobel people would ignore a call that said 'No Caller ID' but he answered to find Sir Alex Ferguson on the other end of the professor, who was himself knighted in 2022, said he thought one of his friends had been joking with him by pretending to be Sir he recognised that the voice sounded too similar to the former Manchester United football manager. The two spoke about their common ground of growing up in Glasgow and the pair are now good friends who will be watching Manchester United play Chelsea together later in the year. Prof MacMillan not only sits next to Sir Alex at football games, the two will now feature together in the National Portrait Gallery of Scotland as the Scots chemist has had his portrait Scots scientist said he was "blown away by it".The painting by Christabel Blackburn depicts the chemist sitting in his office with a white lab coat in the corner. Prof MacMillan said it was actually a lab coat that he was "quite proud of" because it had been presented to him from his old school Bellshill Academy - which now sits in his office in Princeton University.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store